TNFSF10 and urinary bladder carcinoma: Consequently, this study suggests the potential therapeutic efficacy of SFN in conjunction with TRAIL as an adjunctive chemotherapeutic regimen for patients with TRAIL-resistant bladder carcinoma [70].